SG11202004234SA - A zika virus chimeric polyepitope comprising non-structural proteins and its use in an immunogenic composition - Google Patents

A zika virus chimeric polyepitope comprising non-structural proteins and its use in an immunogenic composition

Info

Publication number
SG11202004234SA
SG11202004234SA SG11202004234SA SG11202004234SA SG11202004234SA SG 11202004234S A SG11202004234S A SG 11202004234SA SG 11202004234S A SG11202004234S A SG 11202004234SA SG 11202004234S A SG11202004234S A SG 11202004234SA SG 11202004234S A SG11202004234S A SG 11202004234SA
Authority
SG
Singapore
Prior art keywords
immunogenic composition
structural proteins
zika virus
chimeric polyepitope
virus chimeric
Prior art date
Application number
SG11202004234SA
Other languages
English (en)
Inventor
Claude Roth
Etienne Simon-Loriere
Anavaj Sakuntabhai
Felix Delgado
Original Assignee
Pasteur Institut
Univ El Bosque
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Univ El Bosque filed Critical Pasteur Institut
Publication of SG11202004234SA publication Critical patent/SG11202004234SA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/18—Togaviridae; Flaviviridae
    • C07K14/1816—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus), border disease virus
    • C07K14/1825—Flaviviruses or Group B arboviruses, e.g. yellow fever virus, japanese encephalitis, tick-borne encephalitis, dengue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11202004234SA 2017-11-09 2018-11-08 A zika virus chimeric polyepitope comprising non-structural proteins and its use in an immunogenic composition SG11202004234SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17306553 2017-11-09
PCT/EP2018/080677 WO2019092142A1 (en) 2017-11-09 2018-11-08 A zika virus chimeric polyepitope comprising non-structural proteins and its use in an immunogenic composition

Publications (1)

Publication Number Publication Date
SG11202004234SA true SG11202004234SA (en) 2020-06-29

Family

ID=60574493

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202004234SA SG11202004234SA (en) 2017-11-09 2018-11-08 A zika virus chimeric polyepitope comprising non-structural proteins and its use in an immunogenic composition

Country Status (12)

Country Link
US (2) US11305003B2 (de)
EP (1) EP3707154A1 (de)
JP (1) JP7225254B2 (de)
KR (1) KR20200090186A (de)
CN (1) CN111683959A (de)
AU (1) AU2018365296B2 (de)
BR (1) BR112020009157A2 (de)
CA (1) CA3079776A1 (de)
MX (1) MX2020004833A (de)
PH (1) PH12020550569A1 (de)
SG (1) SG11202004234SA (de)
WO (1) WO2019092142A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11806393B2 (en) * 2017-02-10 2023-11-07 La Jolla Institute For Allergy And Immunology Flavivirus peptide sequences, epitopes, and methods and uses thereof
EP3707154A1 (de) 2017-11-09 2020-09-16 Institut Pasteur Chimäres polyepitop des zika-virus mit nichtstrukturellen proteinen und dessen verwendung in einer immunogenen zusammensetzung
CN113528465B (zh) * 2020-04-20 2023-07-11 中国人民解放军军事科学院军事医学研究院 包含突变的寨卡病毒全基因组cDNA的DNA分子及其应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2427139T3 (es) 2002-06-20 2013-10-29 Institut Pasteur Virus recombinantes del sarampión que expresan epítopos de antígenos de virus de ARN y uso de los virus recombinantes para la preparación de composiciones de vacuna
ATE437175T1 (de) 2002-06-20 2009-08-15 Pasteur Institut Infektiöse cdna eines zugelassenen impfstammes des masern virus. verwendung in immunogenen zusammensetzungen
FR2870126B1 (fr) 2004-05-17 2009-07-17 Pasteur Institut Vecteur lentiviral recombinant d'expression d'une proteine de flaviviridae et ses applications comme vaccin
US8158413B2 (en) 2005-10-17 2012-04-17 Institut Pasteur Lentiviral vector-based vaccine
ES2423518T3 (es) 2006-12-22 2013-09-20 Institut Pasteur Células y metodología para generar virus de ARN de cadena de sentido negativo no segmentada
CN102083462B (zh) 2007-08-03 2015-02-18 巴斯德研究院 慢病毒基因转移载体及其医学应用
WO2012135805A2 (en) 2011-03-31 2012-10-04 modeRNA Therapeutics Delivery and formulation of engineered nucleic acids
WO2013039861A2 (en) 2011-09-12 2013-03-21 modeRNA Therapeutics Engineered nucleic acids and methods of use thereof
EP2712871A1 (de) 2012-09-27 2014-04-02 Institut Pasteur Rekombinantes Masernvirus zur Expression von Chikungunya-Virus-Polypeptiden und deren Anwendungen
US20170173128A1 (en) 2013-12-06 2017-06-22 Moderna TX, Inc. Targeted adaptive vaccines
EP2959915A1 (de) * 2014-06-23 2015-12-30 Institut Pasteur Chimäres Dengue-Virus-Polyepitop aus Fragmenten nichtstruktureller Proteine und deren Verbindung in einer immunogenen Zusammensetzung gegen Dengue-Virus-Infektion
EP3031923A1 (de) 2014-12-11 2016-06-15 Institut Pasteur Lentivirale, vektorbasierte immunogene Zusammensetzung gegen Japanische Enzephalitis
GB201508099D0 (en) * 2015-05-12 2015-06-24 Isis Innovation Dengue vaccines
EP3310382A4 (de) * 2015-06-22 2019-01-02 President and Fellows of Harvard College Zusammensetzungen und verfahren zur modulation viraler infektionen
MX2018009917A (es) * 2016-02-17 2019-08-14 Curevac Ag Vacuna contra el virus del zika.
WO2017189891A1 (en) * 2016-04-27 2017-11-02 Middle Tennessee State University Methods for treating zika viral infections and associated complications
BR112018077540A2 (pt) * 2016-07-08 2019-10-01 Us Health vírus quimérico da dengue/zika como vacinas de zika vírus vivo atenuado
US10632185B2 (en) * 2016-07-08 2020-04-28 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Chimeric west nile/zika viruses and methods of use
US11666649B2 (en) * 2016-10-11 2023-06-06 University Of Miami Vectors and vaccine cells for immunity against Zika virus
AU2017405996A1 (en) * 2017-03-27 2019-10-10 The University Of Queensland Chimeric insect-specific flaviviruses
EP3707154A1 (de) 2017-11-09 2020-09-16 Institut Pasteur Chimäres polyepitop des zika-virus mit nichtstrukturellen proteinen und dessen verwendung in einer immunogenen zusammensetzung

Also Published As

Publication number Publication date
US20200282043A1 (en) 2020-09-10
WO2019092142A1 (en) 2019-05-16
CA3079776A1 (en) 2019-05-16
BR112020009157A2 (pt) 2020-10-27
US11305003B2 (en) 2022-04-19
JP2021502115A (ja) 2021-01-28
MX2020004833A (es) 2021-01-08
AU2018365296B2 (en) 2023-11-23
EP3707154A1 (de) 2020-09-16
CN111683959A (zh) 2020-09-18
PH12020550569A1 (en) 2021-04-19
JP7225254B2 (ja) 2023-02-20
KR20200090186A (ko) 2020-07-28
US11872276B2 (en) 2024-01-16
US20220233678A1 (en) 2022-07-28
AU2018365296A1 (en) 2020-05-21

Similar Documents

Publication Publication Date Title
HUS2300022I1 (hu) Készítmények és eljárások vakcinák dengue vírus kiméra-konstrukcióihoz
ZA201701851B (en) Fmdv recombinant vaccines and uses thereof
HK1231490A1 (zh) 修飾的抗原結合多肽構建體及其用途
SG11201610731VA (en) A dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection
HK1246318A1 (zh) 乙型肝炎病毒核心蛋白和表面抗原蛋白以及包含其的疫苗
SG11201606624WA (en) Antibody moleules to dengue virus and uses thereof
IL275427A (en) Hepatitis virus vaccines HBV) B) and their uses
SG11202004234SA (en) A zika virus chimeric polyepitope comprising non-structural proteins and its use in an immunogenic composition
IL264009A (en) Antibodies with low immunogenicity and their uses
HK1257191A1 (zh) 重組火雞疱疹病毒疫苗及其用途
IL249368B (en) map44 polypeptides and structures based on natural antibodies and their uses
SG10201912925SA (en) Antibodies that bind zika virus envelope protein and uses thereof
IL270989A (en) Oncolytic virus and method
HK1205148A1 (en) Proteins and methods used to prepare hepatitis e virus-like particles
HK1258695A1 (zh) Fmdv和e2的融合蛋白質及其用途
EP3664846A4 (de) Antikörper gegen epstein-barr-virus und dessen verwendungen
EP3013852A4 (de) Verfahren und zusammensetzungen für dengue-virus-impfstoffe
EP3131875A4 (de) Allenamid als orthogonaler griff für selektive modifizierung von cystein in peptiden und proteinen
SG11201606237RA (en) Hcv chimeric vaccine with influenza virus as vector and preparation method thereof
EP2868665A4 (de) Hcv-b-zell-epitop-peptid puhi26 und anwendungen davon
ZA202104076B (en) Hepatitis b virus vaccine and uses thereof
GB201707286D0 (en) Improvements in or relating to vaccines and bac cloning
AU2017903197A0 (en) Antibody to epstein barr virus and uses thereof
TH1501005277A (th) องค์ประกอบ และวิธีการสำหรับชุดโครงสร้างไคมีริกไวรัสเด็งกีในวัคซีน
GB201619551D0 (en) Prokaryotic Argonaute proteins and uses thereof